CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients

High grade non-muscle-invasive bladder tumours are treated with transurethral resection followed by recurrent intravesical instillations of Bacillus Calmette Guérin (BCG). Although most bladder cancer patients respond well to BCG, there is no clinical parameter predictive of treatment response, and...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Eva Castellano, Célia Samba, Gloria Esteso, Laura Simpson, Elena Vendrame, Eva M. García‐Cuesta, Sheila López‐Cobo, Mario Álvarez-Maestro, Ana Linares, Asier Leibar, Thanmayi Ranganath, Hugh T. Reyburn, Luis Martínez‐Piñeiro, Catherine Blish, Mar Valés‐Gómez
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-09-01
Edice:	Frontiers in Immunology
Témata:	bladder cancer BCG - Bacille Calmette-Guérin vaccine granulocytes leukocytes immune response mass cytometry (CyTOF)
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.970931/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!